Toll-like receptor 9 (TLR9) is a vital part of the innate immune system that has been programmed to identify unmethylated CpG DNA motifs. TLR9 is used as a sensor of endogenous DNA released in case of cell damage, which is associated with inflammatory and autoimmune diseases such as arthritis. Although qualitative connections are drawn, it has no quantitative synthesis of its effect in different animal models.  A systematic search was done to locate 142 records as per PRISMA guidelines. Upon the processes of animal-specific data and quantitative reporting screening, 7 studies were incorporated into a random-effects meta-analysis. The most appreciable results were those of the Weighted Mean Difference (WMD) of IL-6 levels and scores of clinical arthritis in TLR9-knockout (KO)-or inhibited models and Wild-Type (WT)- controls. TLR9 deficiency or pharmacological antagonism resulting in a substantial decrease in clinical arthritis severity was observed in the meta-analysis, and the pooled reduction was 47% in T-cell-dependent models like Collagen-Induced Arthritis (CIA) and Pristane-Induced Arthritis (PIA). TLR9 activation was statistically connected with a burst of systemic IL-6 with a pooled WMD of 212.45 pg/mL (95%CI: 145.2, 279.7; P<0.001). On the other hand, T-cell independent models, such as the K/BxN serum transfer, presented insignificant differences (MD: -0.1), demonstrating a stage-specificity of TLR9. TLR9 is an important underlying quantitative factor of the cytokine storm during the initiation of arthritis. These results support a sound statistical foundation for therapeutic intervention of the TLR9 pathway to attenuate initial immunogenic cascades of mediators.

To Cite This Article: Gong H, Shi M, Zhang Y, Ozaydin I and Zhong Q, 2026. TLR9 receptors and arthritis immunogenic mediators: quantitative meta-analysis in animal models. Pak Vet J, 46(4): 982-986. http://dx.doi.org/10.29261/pakvetj/2026.088